Detalles de la búsqueda
1.
Subjective Outcome after Discontinuation of Botulinum Toxin-A Detrusor Injection for Lower Urinary Tract Disorders: The Majority Suffers!
Urol Int
; 107(3): 263-272, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717940
2.
A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.
J Urol
; 193(2): 570-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25219699
3.
[The Onkonet database: taking stock of an Internet-based, multi-centre database on surgical prostate cancer treatment]. / Die Onkonet-Datenbank: Bilanz einer Internet-basierten, multizentrischen Dokumentationsplattform zur Erfassung der operativen Therapie des Prostatakarzinoms.
Aktuelle Urol
; 53(1): 75-81, 2022 Feb.
Artículo
en Alemán
| MEDLINE | ID: mdl-31195415
4.
Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure.
Int J Urol
; 15(5): 407-15; discussion 415, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18452456
5.
Results of Use of Tissue-Engineered Autologous Oral Mucosa Graft for Urethral Reconstruction: A Multicenter, Prospective, Observational Trial.
EBioMedicine
; 23: 185-192, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28827035
6.
A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study.
Eur Urol
; 69(1): 94-102, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26283011
7.
Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in Europe.
Adv Drug Deliv Rev
; 82-83: 181-91, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25446139
8.
180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.
Eur Urol
; 65(5): 931-42, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331152
9.
Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2X2, and P2X3 receptors in children and adolescents who have neurogenic detrusor overactivity: a single-blind study.
Urology
; 81(5): 1052-7, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23419459
10.
Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term study.
J Pediatr Urol
; 8(4): 386-92, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21907623
11.
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.
Eur Urol
; 56(3): 495-503, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19560257
12.
Antibodies against botulinum neurotoxin type A as a cause of treatment failure after the first detrusor injection.
Urology
; 69(3): 575.e13-5, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17382174
13.
Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment.
BJU Int
; 100(5): 1075-80, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17784887
14.
Neuromodulatory therapies in female pelvic medicine and reconstructive surgery: biological agents.
BJU Int
; 98 Suppl 1: 50-60; discussion 61, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16911604
15.
Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis.
BJU Int
; 97(2): 355-8, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16430646
16.
Surgery is inadvisable: massive varicocele due to portal hypertension.
Int J Urol
; 12(9): 852-4, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16201987
17.
Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction.
Urology
; 66(1): 82-7, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15992872
18.
Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity.
Urology
; 66(4): 865-70; discussion 870, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16230156
19.
Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.
Eur Urol
; 48(6): 984-90; discussion 990, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16126328
20.
Orandi one-stage urethroplasty using the subcutaneous pedicle graft modification of Raatzsch--long-term results.
Scand J Urol Nephrol
; 38(4): 321-5, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15669592